V. Rider et al., Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells, CLIN IMMUNO, 95(2), 2000, pp. 124-134
Previous experiments in our laboratory indicated that calcineurin expressio
n and PP2B phosphatase activity increased when estrogen was cultured with S
LE T cells but not with T cells from normal women. In this report we extend
ed our findings to show that estrogen receptor (ER) antagonism by ICI 182,7
80 inhibited the estrogen dependent increase in calcineurin mRNA and phosph
atase PP2B activity indicating that estrogen action was mediated through th
e ER. Inhibition of de novo protein synthesis with cycloheximide suggested
that the estrogen-dependent increase in T cell calcineurin mRNA was a direc
t effect of the ER and new protein synthesis was not required. Estrogen inc
reased calcineurin mRNA in systemic lupus erythematosus (SLE) T cells at 6
h after the start of culture correlating with increased phosphatase activit
y at this same time. Phosphatase activity increased significantly (P < 0.02
) in lupus T cells cultured for 8 h in estradiol containing medium. Reverse
transcription and polymerase chain amplification revealed that ER-beta and
ER-alpha were expressed in female and male T cells from SLE patients and n
ormal controls. However, calcineurin steady-state mRNA levels were unaffect
ed by estradiol in cultured T cells from male SLE patients and normal male
and female controls. These data indicate that estrogen, bound to the ER, ev
okes a direct increase in calcineurin expression in T cells from female lup
us patients. This gender-specific response suggests that ER function is alt
ered in women with the female predominant autoimmune disease, SLE. (C) 2000
Academic Press.